Logo Image
News
All NewsFDA UpdatesPress Releases
Watch
Expert ConversationsNews & AnalysisShows & PodcastsSponsored Webcast
Conferences
Conference CoverageConference Listing
Publications
All PublicationsPharmacy TimesPharmacy Practice in Focus: OncologyPharmacy Practice in Focus: Health SystemsPharmacy CareersAuthor SubmissionSubmit to Pharmacy Practice in Focus: OncologySubmit to Pharmacy Practice in Focus: Health SystemsBecome a Peer ReviewerSupplements & Featured Publications
More
Events
Upcoming EventsUpcoming Webinars
CE
Resources
Clinical ForumAmerican Heart MonthThe Bispecifics NetworkEducated PatientInformation for the PharmacistInteractive ToolsMicrositesPartnersPulsePointSponsoredWhiteboards

Subscribe

  • News
  • Watch
  • Conferences
  • Publications
  • Events
  • CE
  • Resources
  • Subscribe
  • 503B Compounding Pharmacy
  • Allergy
    • Asthma
  • Biosimilars
  • Cardiovascular Health
    • Heart Failure
    • Cholesterol
  • Chronic Kidney Disease
  • Classical Hematology
    • Immunoglobulins
    • Neutropenia
  • Dermatology
    • Psoriasis
    • Atopic Dermatitis
  • Endocrinology
    • Continuous Glucose Monitoring
    • Diabetes
    • Osteoporosis
  • Eye Care
    • Macular Degeneration
    • Dry Eye Disease
  • Future of Pharmacy
  • Gastrointestinal Health
    • Digestive Health
  • Hematology
    • Multiple Myeloma
    • Lymphoma
    • Myelofibrosis
    • Chronic Lymphocytic Leukemia
  • Hepatitis/MASH
  • Infectious Disease
    • Respiratory Syncytial Virus
    • Pneumococcal
    • C. difficile
    • COVID-19
    • Flu
    • HIV
    • PrEP
    • COVID Treatment
  • Neurology
    • Multiple Sclerosis
    • Alzheimer Disease
    • Epilepsy
    • Migraine
    • Sleep
    • Shingles
    • Alzheimer Disease
    • Movement Disorders
    • Parkinson Disease
  • Oncology
    • Cholangiocarcinoma
    • Endometrial Cancer
    • Immuno-oncology
    • Genitourinary Cancer
    • Lung Cancer
    • Prostate Cancer
    • Skin Cancer
    • Ovarian Cancer
    • Breast Cancer
    • Cervical Cancer
    • Gastrointestinal Cancer
    • Colorectal Cancer
    • HER2 Breast Cancer
  • Pain Management
  • Pediatrics
  • Psychiatry
    • Psychedelics
    • Schizophrenia
    • ADHD
    • Brain Health
    • Mental Health
    • Bipolar Disorder
    • Anxiety
    • Depression
  • Pulmonology
    • COPD
    • Cough and Cold
  • Rheumatology
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
  • Vaccines
    • Travel Vaccines
  • Veterinary Pharmacy
  • Vitamins and Supplements
  • Weight Management
  • Women's Health
    • Reproductive Health
Spotlight -
Community/Retail|
Hospital|
Oncology|
Pharmacy Technician|
Student
Advertisement

Eugene Wright, MD

Advertisement

Articles by Eugene Wright, MD

Early Detection and Interconnected Risk: The Role of Albuminuria in Kidney and Cardiovascular Disease

ByEugene Wright, MD,Danielle Valletti, Assistant Editor
March 25th 2026

Albuminuria (uACR) flags early vascular damage linking chronic kidney disease and cardiovascular risk.

Chronic kidney disease, doctor holding model for treatment urinary system, urology, Estimated glomerular filtration rate eGFR. | Image Credit: manassanant | stock.adobe.com

Using uACR as an Early Warning Signal for Kidney and Cardiovascular Risk

ByEugene Wright, MD,Danielle Valletti, Assistant Editor
March 23rd 2026

Connecting Kidney, Heart, and Metabolic Health Through uACR Screening

ByEugene Wright, MD,Danielle Valletti, Assistant Editor
March 20th 2026

Learn why uACR screening flags early vascular damage linking chronic kidney disease and cardiovascular health.

Advertisement

Latest Updated Articles

  • Early Detection and Interconnected Risk: The Role of Albuminuria in Kidney and Cardiovascular Disease
    Early Detection and Interconnected Risk: The Role of Albuminuria in Kidney and Cardiovascular Disease

    March 25th 2026

  • Connecting Kidney, Heart, and Metabolic Health Through uACR Screening
    Connecting Kidney, Heart, and Metabolic Health Through uACR Screening

    March 20th 2026



Advertisement
Advertisement

Trending on Pharmacy Times

1

Nearly Two-Thirds of Patients With Long COVID Meet Diagnostic Criteria for POTS

2

After 180 Years, Multiple Myeloma Gets a Definition of Cure

3

Influenza Vaccines Continue to Reduce Severe Disease and Death Across High-Risk Groups, Evidence Review Finds

4

Psilocybin-Assisted Therapy for AUD: Emerging Evidence, Clinical and Cost Implications, and Treatment Gaps

5

Teclistamab-Daratumumab Intensification Achieves 73% MRD-Negative CR Rate in High-Risk Multiple Myeloma

  • About Us
  • Clinical Forums
  • Advertise
  • Contact Us
  • Editorial Staff
  • Privacy Policy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contemporary Clinic
  • OTC Guide
  • Pharmacy Times
  • Pharmacist Mom's Group
  • Pharmacist Mom's Group
Pharmacy Times
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us